Researchers with Pfizer and IBM developed an artificial intelligence (AI) model that they claim can predict the eventual onset of Alzheimer’s disease with 71% accuracy based on a language sample.
The U.S. National Institutes of Health (NIH) awarded seven companies and academic institutions grants to develop digital health technology to help with the Covid-19 pandemic.
EVERSANA launched ACTICS by EVERSANA, a technology-enabled solution to optimize end-to-end commercial success for life science companies.
Med Ad News spoke with Nick Bartolomeo and Bryan O’Malley about their new roles at Fingerpaint and the creation of the SHIFT Performance™ Center of Excellence, the capabilities of SHIFT’s AI, the launch of Actionable Intelligence Engine™, and how they think SHIFT will be able to help clients in a proven, science-driven way.
Fingerpaint, a full-service health and wellness marketing agency with five offices across the United States and almost $80 million in revenue, announced the creation of the SHIFT Performance Center of Excellence and the launch of its proprietary Actionable Intelligence Engine.
The healthcare industry is increasingly focusing on niche patient populations. However, finding hard-to-reach rare disease patients is difficult and keeping them engaged over time even more so. Could machine learning platforms that deliver personalized experiences for patients and caregivers be part of the answer?
Everyone knows the terms “machine learning” and “artificial intelligence.” Few can define them, much less explain their inestimable value to clinical trials. So, it’s not surprising that, despite their ability to minimize risk, improve safety, condense timelines, and save costs, these technology tools are not widely used by the clinical trial industry.
AiCure’s phone app helps clinical trials keep tabs on which participants have taken their medications correctly and which have not.
Frost & Sullivan IDs Five New Technologies to Power Research Across Preclinical Disease Models Published: July 16, 2020 BioSpace When the CEOs of young, innovative biotech companies discuss how their new technologies came to be, they almost inevitably mention a convergence of technologies that was pivotal in transforming an idea into a therapeutic, diagnostic, tool […]
EVERSANA, a leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform.